Hydergine en es it fr

Hydergine Brand names, Hydergine Analogs

Hydergine Brand Names Mixture

  • No information avaliable

Hydergine Chemical_Formula


Hydergine RX_link

No information avaliable

Hydergine fda sheet

Hydergine msds (material safety sheet)

Hydergine Synthesis Reference

No information avaliable

Hydergine Molecular Weight

591.741 g/mol

Hydergine Melting Point

No information avaliable

Hydergine H2O Solubility

No information avaliable

Hydergine State


Hydergine LogP


Hydergine Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Hydergine Indication

For use as an adjunct therapy for patients with dementia

Hydergine Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Hydergine Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Hydergine side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Hydergine Patient Information

No information avaliable

Hydergine Organisms Affected

Humans and other mammals